Fri Aug 01 10:44:29 UTC 2025: **FOR IMMEDIATE RELEASE**
**Trump Demands Pharmaceutical Giants Lower U.S. Drug Prices**
**Washington D.C. – August 1, 2025** – In a bold move aimed at curbing rising healthcare costs, U.S. President Donald Trump has directly intervened to challenge the pharmaceutical industry. He has sent personal letters to the CEOs of 17 major pharmaceutical companies, including Novartis CEO Vasant Narasimhan, demanding an immediate commitment to lower drug prices for American consumers.
The letters, disclosed at a White House briefing on Thursday, give the pharmaceutical companies until September 29, 2025, to pledge to offer Americans the same drug prices charged in Europe and other developed nations. White House Press Secretary Karoline Leavitte characterized the move as an escalation in the administration’s fight against “abusive drug pricing practices.”
“For too long, Americans have paid more than triple for the same life-saving medications compared to other countries,” Ms. Leavitte stated. “President Trump says this injustice ends now.”
The President’s letters outlined four key demands: extending global parity pricing to Medicaid, applying fair pricing to new drugs, redirecting overseas profits to benefit American patients, and enabling direct consumer purchases at internationally benchmarked prices.
President Trump also warned companies that failure to comply could result in the White House deploying “every tool in our arsenal.”
The move comes amidst growing public concern over the affordability of prescription drugs. The briefing included an emotional letter from an Ohio mother struggling to afford insulin for her son, highlighting the human cost of high drug prices.
“This is about people,” Ms. Leavitte emphasized. “Families are being forced to choose between rent and medicine.”
First Piper 